We found IRF5 and IFNB1 to be induced in ND COVID‐19 (respectively, 7.3‐ and 1.8‐fold increase relative to non‐COVID‐19 patients with T2D; Appendix Fig S3A) and with an exaggerated increase in T2D COVID‐19 patients (respectively, 1.5‐ and 2.0‐fold increase relative to ND COVID‐19 patients; Fig 3A). This evidence concerns the gene IRF5 and COVID-19.